Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 21.789% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) N#CCCn1c(O)c(N=NC(=O)CNC(=O)c2cccs2)c2ccccc21
b) COC(=O)C1(Cc2ccc(O)c(CC3OC3(C)C)c2)OC(=O)C(O)=C1c1ccc(O)cc1
c) CCC(C)[C@H](NC(=O)NCc1cccnc1)C(=O)OC
Answer: c. CCC(C)[C@H](NC(=O)NCc1cccnc1)C(=O)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)[C@H](NC(=O)NCc1cccnc1)C(=O)OC
CCC(C)[C@H](NC(=O)NCc1cccnc1)C(=O)OC
methyl (2S)-3-methyl-2-(pyridin-3-ylmethylcarbamoylamino)pentanoate